Official Title: Culturally-Tailored Avatar-Led MHealth Intervention to Aid Smoking Cessation Among Sexual and Gender Minority Young Adults in New Mexico
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This clinical trial assesses the acceptability and efficacy of Empowered Queer Quitting and Living--New Mexico EQQUAL-NM a smoking cessation intervention for sexual and gender minority young adults in New Mexico Smoking prevalence among sexual and gender minority SGM adults in New Mexico is more than twice as high as non-SGM adults Helping young adult tobacco users to quit is critical yet there have been few efforts to develop tailored treatments specifically for this population EQQUAL-NM is a digital smoking cessation intervention designed specifically for SGM young adult smokers in New Mexico and may help them quit smoking
Detailed Description: OUTLINE
Participants are randomized to 1 of 2 groups
GROUP I Participants receive access to a self-guided smartphone app-delivered quit smoking program called EQQUAL-NM Program A that helps explore personal values and teaches participants about smoking triggers and skills to help them manage cravings and accept thoughts and feelings related to smoking Participants receive text message reminders and prompts on study Some participants also undergo collection of a saliva sample during follow-up
GROUP II Participants receive access to a self-guided smartphone app-delivered quit smoking program called EQQUAL-NM Program B that is based on current clinical practice guidelines for tobacco cessation to help them quit smoking This program helps with quit advice tracking progress on quitting smoking and managing cravings Participants receive text message reminders and prompts on study Some participants also undergo collection of a saliva sample during follow-up
After completion of study intervention patients are followed up at 3 months
Study Oversight
Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID
Type
Domain
Link
NCI-2024-02453
REGISTRY
None
None
RG1124189
OTHER
None
None
U54CA132381
NIH
Fred HutchUniversity of Washington Cancer Consortium